Biotech & pharma
Dassault expands life sciences business with $5.8 billion Medidata deal
14 Jun 2019
French aerospace and defence major Dassault Systemes has been expanding its operations into digital transformation and life sciences industry beginning 2012
And now, hybrid microbes consume CO2 to produce biodegradable plastics, fuel
12 Jun 2019
US researchers have used light-activated quantum dots to fire particular enzymes within microbial cells to create “living factories” that eat harmful carbon dioxide and convert it into useful products such as biodegradable plastic, gasoline, ammonia and biodiesel
Indian agri-food scientists develop coloured wheat varieties
07 May 2019
Black wheat developed by the NABI, for instance, may help prevent fat deposition, control glucose levels, improve insulin tolerance and lower blood cholesterol, as indicated by mouse studies at NABI
Biosensor 'bandage' collects and analyzes sweat
18 Apr 2019
A biosynthetic dual-core cell computer
17 Apr 2019
GE to sell biopharma business to Danaher for $21.4 billion
26 Feb 2019
The reversal of an earlier decision not to sell the biopharma business will accelerate GE’s strategy to reduce leverage and strengthen its core healthcare businesses thereby strengthening its balance sheet
Growing a brain
19 Dec 2018
Latest articles
Featured articles
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.


